These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27013130)

  • 21. Uricase-deficient rats with similarly stable serum uric acid to human's are sensitive model animals for studying hyperuricemia.
    Gao Y; Yu Y; Qin W; Fan N; Qi Y; Chen H; Duan W
    PLoS One; 2022; 17(3):e0264696. PubMed ID: 35239728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization, efficacy, pharmacokinetics, and biodistribution of 5kDa mPEG modified tetrameric canine uricase variant.
    Zhang C; Fan K; Luo H; Ma X; Liu R; Yang L; Hu C; Chen Z; Min Z; Wei D
    Int J Pharm; 2012 Jul; 430(1-2):307-17. PubMed ID: 22503989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the uricase-inhibited rat as an animal model in toxicology.
    Stavric B; Nera EA
    Clin Toxicol; 1978; 13(1):47-74. PubMed ID: 367691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uricase from Bacillus fastidious loaded in alkaline enzymosomes: enhanced biochemical and pharmacological characteristics in hypouricemic rats.
    Tan Q; Zhang J; Wang N; Li X; Xiong H; Teng Y; He D; Wu J; Zhao C; Yin H; Zhang L
    Eur J Pharm Biopharm; 2012 Sep; 82(1):43-8. PubMed ID: 22705639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-Based Immunogenicity Prediction of Uricase from Fungal (Aspergillus flavus), Bacterial (Bacillus subtillis) and Mammalian Sources Using Immunoinformatic Approach.
    Tripathi S; Parmar J; Kumar A
    Protein J; 2020 Apr; 39(2):133-144. PubMed ID: 32221804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia.
    Sands E; Kivitz A; DeHaan W; Leung SS; Johnston L; Kishimoto TK
    Nat Commun; 2022 Jan; 13(1):272. PubMed ID: 35022448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties.
    Nyborg AC; Ward C; Zacco A; Chacko B; Grinberg L; Geoghegan JC; Bean R; Wendeler M; Bartnik F; O'Connor E; Gruia F; Iyer V; Feng H; Roy V; Berge M; Miner JN; Wilson DM; Zhou D; Nicholson S; Wilker C; Wu CY; Wilson S; Jermutus L; Wu H; Owen DA; Osbourn J; Coats S; Baca M
    PLoS One; 2016; 11(12):e0167935. PubMed ID: 28002433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rasburicase therapy may cause hydrogen peroxide shock].
    Góth L
    Orv Hetil; 2008 Aug; 149(34):1587-90. PubMed ID: 18708312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout.
    Tan PK; Farrar JE; Gaucher EA; Miner JN
    Mol Biol Evol; 2016 Sep; 33(9):2193-200. PubMed ID: 27352852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase.
    Abuchowski A; Karp D; Davis FF
    J Pharmacol Exp Ther; 1981 Nov; 219(2):352-4. PubMed ID: 7288624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypouricaemic effect after oral administration in chickens of polyethylene glycol-modified uricase entrapped in liposomes.
    Nishida Y; Kamatani N; Miyamoto T
    J Pharm Pharmacol; 1984 May; 36(5):354-5. PubMed ID: 6145782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA shuffling of uricase gene leads to a more "human like" chimeric uricase with increased uricolytic activity.
    Chen J; Jiang N; Wang T; Xie G; Zhang Z; Li H; Yuan J; Sun Z; Chen J
    Int J Biol Macromol; 2016 Jan; 82():522-9. PubMed ID: 26526169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.
    Terkeltaub R; Bushinsky DA; Becker MA
    Arthritis Res Ther; 2006; 8 Suppl 1(Suppl 1):S4. PubMed ID: 16820043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomimetic polysaccharide-cloaked lipidic nanovesicles/microassemblies for improving the enzymatic activity and prolonging the action time for hyperuricemia treatment.
    Yang L; Zhang Y; Xie J; Zhong C; He D; Wang T; Li K; Li Y; Shi D; Abagyan R; Yang L; Zhang J
    Nanoscale; 2020 Jul; 12(28):15222-15235. PubMed ID: 32639489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and (pharmaco)kinetics of one single dose of rasburicase in patients with chronic kidney disease.
    Sestigiani E; Mandreoli M; Guardigli M; Roda A; Ramazzotti E; Boni P; Santoro A
    Nephron Clin Pract; 2008; 108(4):c265-71. PubMed ID: 18418005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed, low-dose rasburicase for the treatment or prevention of hyperuricemia in adult oncology patients.
    Herrington JD; Dinh BC
    J Oncol Pharm Pract; 2015 Apr; 21(2):111-7. PubMed ID: 24549060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and expression of recombinant uricase‑expressing genetically engineered bacteria and its application in rat model of hyperuricemia.
    Cai L; Li Q; Deng Y; Liu X; Du W; Jiang X
    Int J Mol Med; 2020 May; 45(5):1488-1500. PubMed ID: 32323736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rasburicase for the treatment and prevention of hyperuricemia.
    Yim BT; Sims-McCallum RP; Chong PH
    Ann Pharmacother; 2003; 37(7-8):1047-54. PubMed ID: 12841818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification with polysialic acid-PEG copolymer as a new method for improving the therapeutic efficacy of proteins.
    Wu J; Lu S; Zheng Z; Zhu L; Zhan X
    Prep Biochem Biotechnol; 2016 Nov; 46(8):788-797. PubMed ID: 26829568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uricase Inhibits Nitrogen Dioxide-Promoted Allergic Sensitization to Inhaled Ovalbumin Independent of Uric Acid Catabolism.
    Ather JL; Burgess EJ; Hoyt LR; Randall MJ; Mandal MK; Matthews DE; Boyson JE; Poynter ME
    J Immunol; 2016 Sep; 197(5):1720-32. PubMed ID: 27465529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.